landiolol has been researched along with Tachycardia, Ventricular in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Futatani, T; Hatasaki, K; Nakagawa, R; Shimao, A | 1 |
| Takahashi, S; Tanaka, M; Yamada, M; Yamashita, S | 1 |
| Daimon, T; Ikeda, T; Kinugawa, K; Nagai, R; Okamoto, H; Oki, K; Sakamoto, A; Shiga, T; Shimizu, W; Yamashita, T | 1 |
| Aoyagi, T; Hayami, N; Inaba, H; Kanamori, K; Kunishima, T; Mikamo, T; Murakawa, Y; Tsutsui, K | 1 |
| Abe, A; Hoshida, K; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Tsukada, T; Yanagisawa, R; Yoshino, H; Yusu, S | 1 |
| Kim, C; Ogawa, R; Sakamoto, A | 1 |
| Kim, C; Kitamura, A; Nakanishi, K; Sakamoto, A; Sato, C; Yokozuka, M | 1 |
| Atarashi, H; Endoh, Y; Hayakawa, H; Ino, T; Kuruma, A; Saitoh, H; Yashima, M | 1 |
3 trial(s) available for landiolol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias　- Outcomes of J-Land II Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Disease-Free Survival; Female; Humans; Japan; Male; Middle Aged; Morpholines; Survival Rate; Tachycardia, Ventricular; Time Factors; Urea | 2019 |
Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Drug Resistance; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Tachycardia, Ventricular; Urea | 2010 |
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2000 |
5 other study(ies) available for landiolol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Successful treatment of neonatal idiopathic ventricular tachycardia with landiolol hydrochloride.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant, Newborn; Morpholines; Remission Induction; Tachycardia, Ventricular; Urea | 2019 |
Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Electric Countershock; Female; Humans; Male; Morpholines; Tachycardia, Ventricular; Treatment Outcome; Urea; Ventricular Fibrillation | 2018 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electrocardiography; Humans; Male; Morpholines; Myocardial Infarction; Tachycardia, Ventricular; Treatment Outcome; Urea | 2015 |
Effect of landiolol on nonsustained ventricular tachycardia during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Electroconvulsive Therapy; Humans; Male; Morpholines; Tachycardia, Ventricular; Urea | 2005 |
Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Depressive Disorder, Major; Electrocardiography; Electroconvulsive Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Preanesthetic Medication; Recurrence; Retreatment; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2007 |